loading

Enliven Therapeutics Inc Aktie (ELVN) Neueste Nachrichten

pulisher
May 22, 2025

Enliven Therapeutics to Present at Upcoming Investor Conferences - PR Newswire

May 22, 2025
pulisher
May 22, 2025

(ELVN) Proactive Strategies - news.stocktradersdaily.com

May 22, 2025
pulisher
May 22, 2025

Enliven Therapeutics chief scientific officer sells $81,533 in stock - Investing.com Australia

May 22, 2025
pulisher
May 21, 2025

Enliven Therapeutics chief scientific officer sells $81,533 in stock By Investing.com - Investing.com India

May 21, 2025
pulisher
May 20, 2025

Enliven Therapeutics, Inc. (NASDAQ:ELVN) Shares Purchased by Northern Trust Corp - Defense World

May 20, 2025
pulisher
May 19, 2025

HC Wainwright Issues Pessimistic Outlook for ELVN Earnings - Defense World

May 19, 2025
pulisher
May 18, 2025

Jones Trading Has Lowered Expectations for Enliven Therapeutics (NASDAQ:ELVN) Stock Price - Defense World

May 18, 2025
pulisher
May 18, 2025

Q1 Earnings Forecast for ELVN Issued By HC Wainwright - Defense World

May 18, 2025
pulisher
May 17, 2025

HC Wainwright Raises Enliven Therapeutics (NASDAQ:ELVN) Price Target to $40.00 - Defense World

May 17, 2025
pulisher
May 16, 2025

Jones Trading Lowers Price Target for Enliven Therapeutics (ELVN) | ELVN Stock News - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Enliven (ELVN) Stock Target Cut Amid Mixed Market Reaction | ELVN Stock News - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Enliven Therapeutics, Inc. (NASDAQ:ELVN) Holdings Lifted by Price T Rowe Associates Inc. MD - Defense World

May 16, 2025
pulisher
May 16, 2025

Enliven Therapeutics (NASDAQ:ELVN) Stock Price Down 7.6% Following Weak Earnings - Defense World

May 16, 2025
pulisher
May 16, 2025

Enliven Therapeutics Reports Q1 Results and Pipeline Progress - TipRanks

May 16, 2025
pulisher
May 15, 2025

Enliven Therapeutics stock target raised to $40 at H.C. Wainwright By Investing.com - Investing.com South Africa

May 15, 2025
pulisher
May 15, 2025

Enliven Therapeutics: Cash runway can fund ops through late 2027 - BizWest

May 15, 2025
pulisher
May 15, 2025

Enliven Therapeutics (ELVN) Target Price Raised by HC Wainwright & Co. | ELVN Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Enliven Therapeutics stock target raised to $40 at H.C. Wainwright - Investing.com Australia

May 15, 2025
pulisher
May 15, 2025

H.C. Wainwright Increases Price Target for Enliven (ELVN) Post Q - GuruFocus

May 15, 2025
pulisher
May 15, 2025

H.C. Wainwright Increases Price Target for Enliven (ELVN) Post Q1 Report | ELVN Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Enliven reports positive Phase 1 trial data for ELVN-001 in CML - Investing.com Nigeria

May 15, 2025
pulisher
May 15, 2025

Tower Research Capital LLC TRC Boosts Stock Holdings in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World

May 15, 2025
pulisher
May 14, 2025

Enliven Therapeutics Reports First Quarter Financial Results and Provides a Business Update - PR Newswire

May 14, 2025
pulisher
May 14, 2025

Enliven reports positive Phase 1 trial data for ELVN-001 in CML By Investing.com - Investing.com South Africa

May 14, 2025
pulisher
May 14, 2025

Enliven Therapeutics Says ELVN-001 Shows Favorable Safety And Tolerability Profile - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

Enliven Therapeutics Announces Updated Positive Data from Phase 1 Clinical Trial of ELVN-001 in CML and Oral Presentation at the EHA 2025 Congress - The Malaysian Reserve

May 14, 2025
pulisher
May 14, 2025

Enliven (ELVN) Reports Positive Results from ENABLE Trial for Chronic Myeloid Leukemia | ELVN Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Breakthrough CML Drug ELVN-001 Achieves 44% Response Rate in Heavily Pretreated PatientsKey Data Revealed - Stock Titan

May 14, 2025
pulisher
May 11, 2025

(ELVN) Investment Analysis - news.stocktradersdaily.com

May 11, 2025
pulisher
May 11, 2025

Enliven Therapeutics (ELVN) Expected to Announce Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 05, 2025

Wells Fargo & Company MN Has $375,000 Stock Holdings in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World

May 05, 2025
pulisher
May 05, 2025

Invesco Ltd. Buys 508 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World

May 05, 2025
pulisher
May 04, 2025

Barclays PLC Has $1.45 Million Holdings in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World

May 04, 2025
pulisher
May 02, 2025

Enliven Therapeutics (NASDAQ:ELVN) Sets New 52-Week Low on Insider Selling - Defense World

May 02, 2025
pulisher
May 02, 2025

JPMorgan Chase & Co. Trims Stock Position in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World

May 02, 2025
pulisher
May 01, 2025

Enliven (ELVN) Gains Attention as EHA Data Release Approaches | - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Trading (ELVN) With Integrated Risk Controls - news.stocktradersdaily.com

May 01, 2025
pulisher
Apr 30, 2025

Enliven Therapeutics, Inc. (NASDAQ:ELVN) Stake Lowered by Legal & General Group Plc - Defense World

Apr 30, 2025
pulisher
Apr 24, 2025

Enliven Therapeutics chief scientific officer sells $80,365 in stock By Investing.com - Investing.com India

Apr 24, 2025
pulisher
Apr 24, 2025

Enliven Therapeutics chief scientific officer sells $80,365 in stock - Investing.com Australia

Apr 24, 2025
pulisher
Apr 23, 2025

Enliven Therapeutics Inc (ELVN) shows promising results - uspostnews.com

Apr 23, 2025
pulisher
Apr 22, 2025

Enliven Therapeutics: Awaiting Additional Trial Data (NASDAQ:ELVN) - Seeking Alpha

Apr 22, 2025
pulisher
Apr 20, 2025

Geode Capital Management LLC Acquires 12,510 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World

Apr 20, 2025
pulisher
Apr 18, 2025

Can you now get a good deal on Enliven Therapeutics Inc’s shares? - uspostnews.com

Apr 18, 2025
pulisher
Apr 15, 2025

(ELVN) Trading Report - news.stocktradersdaily.com

Apr 15, 2025
pulisher
Apr 13, 2025

Vanguard Group Inc. Purchases 55,283 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World

Apr 13, 2025
pulisher
Apr 13, 2025

Enliven Therapeutics, Inc. (NASDAQ:ELVN) Stake Boosted by Wellington Management Group LLP - Defense World

Apr 13, 2025
pulisher
Apr 11, 2025

KLP Kapitalforvaltning AS Makes New $97,000 Investment in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World

Apr 11, 2025
pulisher
Apr 10, 2025

Ratios Revealed: Decoding Enliven Therapeutics Inc (ELVN)’s Financial Health - DWinneX

Apr 10, 2025
pulisher
Apr 10, 2025

Corebridge Financial Inc. Trims Holdings in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World

Apr 10, 2025
pulisher
Apr 09, 2025

Enliven Therapeutics COO Anish Patel sells shares worth $120,268 By Investing.com - Investing.com India

Apr 09, 2025
pulisher
Apr 09, 2025

Enliven Therapeutics COO Anish Patel sells shares worth $120,268 - Investing.com Australia

Apr 09, 2025
$1.15
price down icon 17.27%
$31.32
price down icon 3.63%
$587.61
price up icon 1.06%
$289.96
price up icon 0.33%
$4.25
price up icon 0.48%
$75.06
price up icon 3.26%
Kapitalisierung:     |  Volumen (24h):